KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Recursion Pharmaceuticals (RXRX) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Recursion Pharmaceuticals (RXRX) over the last 5 years, with Q3 2025 value amounting to 0.03.

  • Recursion Pharmaceuticals' Asset Utilization Ratio fell 6273.18% to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year decrease of 6273.18%. This contributed to the annual value of 0.06 for FY2024, which is 1492.24% down from last year.
  • As of Q3 2025, Recursion Pharmaceuticals' Asset Utilization Ratio stood at 0.03, which was down 6273.18% from 0.05 recorded in Q2 2025.
  • In the past 5 years, Recursion Pharmaceuticals' Asset Utilization Ratio registered a high of 0.09 during Q3 2024, and its lowest value of 0.02 during Q3 2021.
  • For the 5-year period, Recursion Pharmaceuticals' Asset Utilization Ratio averaged around 0.05, with its median value being 0.05 (2025).
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first skyrocketed by 27838.07% in 2022, then tumbled by 6273.18% in 2025.
  • Over the past 5 years, Recursion Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.02 in 2021, then skyrocketed by 278.38% to 0.06 in 2022, then increased by 14.34% to 0.07 in 2023, then dropped by 22.05% to 0.05 in 2024, then plummeted by 40.23% to 0.03 in 2025.
  • Its Asset Utilization Ratio was 0.03 in Q3 2025, compared to 0.05 in Q2 2025 and 0.04 in Q1 2025.